Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (11-20 of 902) with videos related to

Pageof 91
Sort By:
Hematology. American Society of Hematology. Education Program|December 5, 2025
POEMS syndrome: diagnosis, treatments, and outcomesAngela Dispenzieri
Hematology. American Society of Hematology. Education Program|December 4, 2016
Myeloma: management of the newly diagnosed high-risk patientAngela Dispenzieri
Blood|April 15, 2017
The yin and yang of autophagy in AL amyloidosisAngela Dispenzieri
Blood|May 1, 2020
AL patients don't dare go without daraAngela Dispenzieri
Blood|October 9, 2008
Biology, treatment, and timeAngela Dispenzieri
Hematology/Oncology Clinics of North America|November 13, 2007
Complications of myeloma therapyAngela Dispenzieri
Blood|June 18, 2011
Ushering in a new era for POEMSAngela Dispenzieri
American Journal of Hematology|September 3, 2015
POEMS syndrome: update on diagnosis, risk-stratification, and managementAngela Dispenzieri
American Journal of Hematology|May 17, 2021
POEMS syndrome: 2021 Update on diagnosis, risk-stratification, and managementAngela Dispenzieri
The Lancet. Oncology|October 4, 2011
Is there a future for auto-allo HSCT in multiple myeloma?Angela Dispenzieri
Pageof 91

Showing results (11-20 of 902) with videos related to

Sort By:
Pageof 91
Hematology. American Society of Hematology. Education Program|December 5, 2025
POEMS syndrome: diagnosis, treatments, and outcomesAngela Dispenzieri
Hematology. American Society of Hematology. Education Program|December 4, 2016
Myeloma: management of the newly diagnosed high-risk patientAngela Dispenzieri
Blood|April 15, 2017
The yin and yang of autophagy in AL amyloidosisAngela Dispenzieri
Blood|May 1, 2020
AL patients don't dare go without daraAngela Dispenzieri
Blood|October 9, 2008
Biology, treatment, and timeAngela Dispenzieri
Hematology/Oncology Clinics of North America|November 13, 2007
Complications of myeloma therapyAngela Dispenzieri
Blood|June 18, 2011
Ushering in a new era for POEMSAngela Dispenzieri
American Journal of Hematology|September 3, 2015
POEMS syndrome: update on diagnosis, risk-stratification, and managementAngela Dispenzieri
American Journal of Hematology|May 17, 2021
POEMS syndrome: 2021 Update on diagnosis, risk-stratification, and managementAngela Dispenzieri
The Lancet. Oncology|October 4, 2011
Is there a future for auto-allo HSCT in multiple myeloma?Angela Dispenzieri
Pageof 91